EcoDrugPlus

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSATEG00000024646
Gene Symbol: GRM2B
3 Cross references
210 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSATEG00000002521
Gene Symbol: GRM3
3 Cross references
212 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSATEG00000001806
Gene Symbol: GRM5A
3 Cross references
212 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSATEG00000007055
Gene Symbol: GRM5B
1 Cross references
216 Possible Orthologues:

Glutaminase A

Ensembl ID : ENSATEG00000012895
Gene Symbol: GLSA
3 Cross references
236 Possible Orthologues:

Glutaminase B

Ensembl ID : ENSATEG00000008833
Gene Symbol: GLSB
2 Cross references
225 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSATEG00000000791
Gene Symbol: GSK3AA
3 Cross references
181 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSATEG00000019676
Gene Symbol: GSK3AB
3 Cross references
187 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta, Genome Duplicate A

Ensembl ID : ENSATEG00000011968
Gene Symbol: GSK3BA
3 Cross references
208 Possible Orthologues:

Gonadotropin-Releasing Hormone Ii Receptor-Like

Ensembl ID : ENSATEG00000013875
Gene Symbol: LOC113154008
2 Cross references
174 Possible Orthologues:

Granzyme E-Like

Ensembl ID : ENSATEG00000025509
Gene Symbol: LOC113152814
2 Cross references
1063 Possible Orthologues:

Growth Hormone Secretagogue Receptor A

Ensembl ID : ENSATEG00000006266
Gene Symbol: GHSRA
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).